What we do Astec LifeSciences manufactures agrochemical active ingredients, intermediates, and pharmaceutical intermediates, catering to global agrochemical and pharmaceutical markets. |
Founded in 1,994 |
Market share Significant exporter with presence in East Asia, Europe, Middle East, and USA; 68% revenues from exports. |
Problem solved Provides essential ingredients for crop protection and pharmaceuticals, enabling global supply chains and addressing agricultural and medical needs. |
Top clients or who we serve Supplies to global agrochemical formulators and pharmaceutical API manufacturers; B2B focus including multinational companies like Syngenta. |
Key management Burjis Nadir Godrej (Managing Director) |
Our journey and innovations Expanded manufacturing from 120 MT in 1994 to over 3150 MT capacity; established global subsidiaries; inaugurated advanced R&D center in 2023. |
Where we operate India with exports to approximately 17 countries including USA, Europe, West Asia, Southeast Asia, Latin America and Africa. |
Top products or what we offer Agrochemical active ingredients, intermediates, bulk formulations, pharmaceutical intermediates, and contract manufacturing services. |
Top brands - |
Raw materials needed Chemical raw materials for agrochemical and pharmaceutical intermediates production. |
Raw materials supplier - |
Recurring vs cyclical contribution Business experiences cyclicality linked to agrochemical industry demand and contract manufacturing volumes; recurring partnerships in CDMO segment. |
Our industry position Major player in Indian agrochemical ingredients market with strong export footprint and established multinational partnerships. |
Financial highlights Revenue: Rs 381.3 Cr (FY 2024-25); Loss after tax: Rs 134.75 Cr; impacted by subdued global demand and pricing pressures. |
Geographical revenue split India: Rs 119.6 Cr (32%), Outside India: Rs 258.55 Cr (68%) |
Order book - |
Whats driving growth Focus on R&D, new herbicide plant commissioning, contract manufacturing expansion, and global client collaborations. |
Our future plans Expand manufacturing capacity, leverage new R&D center, grow CDMO business, and enhance global market presence. |
Our green promise CSR initiatives include bamboo and community development; aligned with Godrej Group's 'Good and Green' sustainability vision. |
Our people and values 555 permanent employees; emphasize safety, diversity, and zero tolerance for workplace harassment. |
Key challenges ahead Market demand volatility, pricing pressures, volume declines, and global agrochemical industry sluggishness. |
Interesting facts Inaugurated 'Adi Godrej Centre for Chemical Research and Development' in 2023 to enhance innovation and CDMO capabilities. |
Risks and strategy Mitigates risks via diversified product base, strategic global partnerships, advanced R&D, and operational efficiency improvements. |
